Group One Trading
ANIX icon

Group One Trading’s Anixa Biosciences ANIX Stock Holding History

Group One Trading’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,100
Closed -$5.42K – 7529
2026
Q1 		$5.42K Sell
2,100
-2,600
-55% -$7.7K ﹤0.01% 6675
2025
Q4 		$14.7K Buy
4,700
+2,100
+81% +$8.6K ﹤0.01% 6577
2025
Q3 		$8.58K Buy
2,600
+1,600
+160% +$5.06K ﹤0.01% 7266
2025
Q2 		$3.3K Sell
1,000
-300
-23% -$857 ﹤0.01% 7244
2025
Q1 		$3.72K Buy
+1,300
New +$3.72K ﹤0.01% 6770
2024
Q4 		– Sell
-800
Closed -$2.52K – 7218
2024
Q3 		$2.52K Buy
+800
New +$2.46K ﹤0.01% 6086
2024
Q1 		– Sell
-2,500
Closed -$9.7K – 6985
2023
Q4 		$9.7K Buy
+2,500
New +$8.43K ﹤0.01% 6225
2023
Q3 		– Sell
-6,900
Closed -$22.1K – 7604
2023
Q2 		$22.1K Buy
+6,900
New +$26.6K ﹤0.01% 5935
2022
Q1 		– Sell
-1,100
Closed -$3K – 7972
2021
Q4 		$3K Buy
+1,100
New +$4.45K ﹤0.01% 7756

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Group One Trading's ANIX Position: Q2 2026 in Review

Group One Trading opened a new position in Anixa Biosciences (ANIX) in Q2 2026: 13,531 shares worth $37.9K. The stake represents ﹤0.01% of the portfolio and ranks #5574 among its holdings. This is a return to the name: Group One Trading previously reported a position in ANIX as recently as Q3 2025.

Group One Trading first reported a position in ANIX in Q2 2023 and has held it in 9 quarters since. The position peaked at $60K in Q3 2024. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Group One Trading held 13,531 shares of Anixa Biosciences worth $37.9K as of Q2 2026.
  • Anixa Biosciences was a new Group One Trading position in Q2 2026.
  • Anixa Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5574 holding.
  • Group One Trading first reported a position in Anixa Biosciences in Q2 2023 and has held it in 9 quarters since.
  • Group One Trading's Anixa Biosciences position peaked at $60K in Q3 2024.
  • 63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.